A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/454 (2006.01) A61K 31/7076 (2006.01) A61K 39/395 (2006.01) A61P 35/02 (2006.01)
Patent
CA 2570755
Methods of treating, preventing or managing leukemias are disclosed. The methods encompass the administration of an immunomodulatory compound of the invention known as Revlimid® or lenalidomide. The invention further relates to methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods of the invention are also disclosed.
La présente invention concerne des méthodes de traitement, de prévention ou de gestion thérapeutique des leucémies. Les méthodes impliquent l'administration d'un composé immunomodulateur selon l'invention appelé Revlimid® ou lénalidomide. Cette invention porte également sur des méthodes de traitement dans lesquelles on utilise ce composé avec la chimiothérapie, la radiothérapie, l'hormonothérapie, la thérapie biologique ou l'immunothérapie; ainsi que sur des compositions pharmaceutiques et des formes posologiques unitaires appropriées pour être utilisées dans les méthodes selon l'invention.
Celgene Corporation
Smart & Biggar
LandOfFree
Methods using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods using... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1533958